Brand Refactoring Refutes “Market Manipulation Allegations” Reports: “Legitimate Investment Distorted”

Brand Refactoring, the largest shareholder of Kosdaq-listed Dong Sung Pharmaceutical, stated on September 26 that recent media reports alleging ...